AVI BioPharma, Inc. Announces Partner’s Advance in Cardiovascular Program

CORVALLIS, OR--(Marketwire - June 16, 2008) - AVI BioPharma, Inc. (NASDAQ: AVII) today announced that its partner in its cardiovascular program, Global Therapeutics, the cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal stent.
MORE ON THIS TOPIC